Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wolfson Berg is a healthcare and biotechnology company primarily focused on the development and distribution of anti-viral and consumer health products. The company is best known for its ViroStop product line, which includes nasal and oral sprays formulated with natural polyphenols intended to provide a physical barrier against viral infections. Wolfson Berg operates as a global entity, often collaborating with research partners to validate the efficacy of its plant-derived formulations. Their portfolio emphasizes preventative care and the management of upper respiratory tract infections through non-systemic treatments. The company maintains a strong presence in the European and Middle Eastern markets through strategic distribution and marketing of its medical device portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wolfson Berg.